Brady W Dougan insider trades
Open-market stock purchases and sales by Brady W Dougan, Director at Humacyte, Inc, from SEC Form 4 filings since Aug 26, 2021.
Track record: 0% of 8 scored buys are up 5% or more since purchase, averaging -73%.
Companies traded
- HUMA Humacyte, Inc: 8 buys, 34 sales, last Jun 11, 2026